acetaminophen has been researched along with pyridoxal phosphate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Aoyagi, N; Ejima, A; Kaniwa, N; Ogata, H | 1 |
| Bazzi, MD; Duhaiman, AS; Rabbani, N | 1 |
| Batteux, F; Bedda, S; Calmus, Y; Chéreau, C; Conti, F; Goulvestre, C; Jaffray, P; Laurent, A; Soubrane, O; Tran, A; Tran-Van Nhieu, J; Weill, B | 1 |
| Dear, J | 1 |
| Ignarro, LJ; Jynge, P; Karlsson, JOG; Lundström, I | 1 |
| Ahmed, M; Ali, A; Athar, MM; Farooq, U; Murtaza, G; Nadeem, K; Salman, M | 1 |
| Black, P; Dear, JW; Gallagher, B; Grahamslaw, J; Henriksen, D; Lee, RJ; Morrison, EE; O'Brien, R; Oatey, K; Oosthuyzen, W; Weir, CJ | 1 |
| Karlsson, JOG | 1 |
| Dear, JW | 1 |
| Freeman, WE; Mullins, ME; Yeager, LH | 1 |
| Akakpo, JY; Jaeschke, H; Ramachandran, A | 1 |
2 review(s) available for acetaminophen and pyridoxal phosphate
| Article | Year |
|---|---|
Metabolic and mitochondrial treatments for severe paracetamol poisoning: a systematic review.
Topics: Acetaminophen; Acetylcysteine; Acidosis; Animals; Antidotes; Cimetidine; Drug Overdose; Edetic Acid; Fomepizole; Humans; Mitochondria; Pyridoxal Phosphate | 2020 |
Novel strategies for the treatment of acetaminophen hepatotoxicity.
Topics: Acetaminophen; Acetylcysteine; Animals; Antidotes; Chemical and Drug Induced Liver Injury; Drug Overdose; Edetic Acid; Fomepizole; Hepatocytes; Humans; Liver Failure, Acute; Pyridoxal Phosphate | 2020 |
2 trial(s) available for acetaminophen and pyridoxal phosphate
| Article | Year |
|---|---|
Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomi
Topics: Acetaminophen; Acetylcysteine; Chemical and Drug Induced Liver Injury; Clinical Trials Data Monitoring Committees; Clinical Trials, Phase I as Topic; Data Interpretation, Statistical; Drug Overdose; Drug Therapy, Combination; Edetic Acid; Female; Humans; Male; Outcome Assessment, Health Care; Pyridoxal Phosphate; Randomized Controlled Trials as Topic; Research Design | 2019 |
Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial).
Topics: Acetaminophen; Acetylcysteine; Adult; Biomarkers; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Overdose; Edetic Acid; Female; Humans; Male; Protective Agents; Pyridoxal Phosphate; Time Factors; Young Adult | 2019 |
8 other study(ies) available for acetaminophen and pyridoxal phosphate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates.
Topics: Acetaminophen; Animals; Aspirin; Biological Availability; Dogs; Dosage Forms; Eating; Gastric Emptying; Humans; Particle Size; Pyridoxal Phosphate; Tablets, Enteric-Coated; Time Factors | 1988 |
Inhibition of camel lens zeta-crystallin by aspirin and aspirin-like analgesics.
Topics: Acetaminophen; Analgesics; Animals; Aspirin; Binding Sites; Binding, Competitive; Camelus; Crystallins; Ibuprofen; In Vitro Techniques; Kinetics; Lysine; NADP; Phenanthrenes; Pyridoxal Phosphate | 2002 |
Mangafodipir prevents liver injury induced by acetaminophen in the mouse.
Topics: Acetaminophen; Animals; Antibodies, Monoclonal; Antioxidants; Carcinoma, Hepatocellular; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cytochromes c; Edetic Acid; Enzymes; fas Receptor; Female; Glutathione; Humans; Liver; Liver Failure, Acute; Liver Neoplasms; Mice; Mice, Inbred BALB C; Oxidoreductases; Pyridoxal Phosphate; Reactive Oxygen Species; Superoxides; Survival Analysis | 2003 |
Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: stud
Topics: Acetaminophen; Acetylcysteine; Drug Overdose; Edetic Acid; Humans; Pyridoxal Phosphate; Research Design | 2019 |
Stability-indicating HPLC-PDA assay for simultaneous determination of paracetamol, thiamine and pyridoxal phosphate in tablet formulations.
Topics: Acetaminophen; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Limit of Detection; Pyridoxal Phosphate; Reproducibility of Results; Tablets; Thiamine | 2019 |
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir?
Topics: Acetaminophen; Acetylcysteine; Edetic Acid; Humans; Pyridoxal Phosphate; Superoxide Dismutase | 2019 |
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir? - Authors' reply.
Topics: Acetaminophen; Acetylcysteine; Edetic Acid; Humans; Pyridoxal Phosphate; Superoxide Dismutase | 2019 |